Reports for TEVA CANADA LIMITED

Company Name
TEVA CANADA LIMITED

Shortage reports

Actual shortage:

214 (7%)

Anticipated shortage:

0 (0%)

Avoided shortage:

10 (0%)

Resolved:

2706 (92%)

2930

Discontinuation Reports

To be discontinued:

2 (1%)

Discontinued:

298 (99%)

Reversed:

0 (0%)

300

363 (11%)

101 (47%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-NAPROXEN 500MG TABLET Resolved 2024-12-19 2025-02-28 246095
TEVA-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2022-12-01 2023-04-28 176779
TEVA-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2022-12-01 2023-04-28 176794
TEVA-NAPROXEN EC 250MG TABLET (ENTERIC-COATED) Resolved 2023-04-27 2023-06-09 190740
TEVA-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2023-06-08 2023-06-21 194094
TEVA-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2021-10-14 2022-02-17 147219
TEVA-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2021-12-02 2022-02-10 150403
TEVA-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2020-09-24 2020-10-22 124986
TEVA-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2023-07-04 2023-07-14 197052
TEVA-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2023-10-05 2023-12-14 206392
TEVA-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2020-03-26 2020-05-08 109583
TEVA-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2024-01-11 2024-03-18 215719
TEVA-NAPROXEN SODIUM 275MG TABLET Resolved 2024-11-08 2025-01-09 242341
TEVA-NAPROXEN SODIUM 275MG TABLET Resolved 2021-10-21 2021-11-05 147708
TEVA-NAPROXEN SODIUM DS 550MG TABLET Actual shortage 2025-04-24 2025-04-24 255684
TEVA-NAPROXEN SODIUM DS 550MG TABLET Resolved 2023-10-19 2023-11-09 207509
TEVA-NAPROXEN SODIUM DS 550MG TABLET Resolved 2022-05-05 2022-06-04 160072
TEVA-NAPROXEN SODIUM DS 550MG TABLET Resolved 2020-06-25 2020-07-23 118954
TEVA-NAPROXEN SODIUM DS 550MG TABLET Resolved 2020-04-03 2020-04-09 110752
TEVA-NAPROXEN SODIUM DS 550MG TABLET Resolved 2021-01-22 2021-03-18 132257
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
METHOTREXATE SODIUM INJECTION 25MG SOLUTION Discontinued 2025-04-25 2025-04-25 255818
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION 40MG POWDER FOR SOLUTION Discontinued 2021-09-23 2021-09-23 146061
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-04-11 2019-04-11 81321
NOVAMOXIN 500MG CAPSULE Discontinued 2017-06-27 2017-06-27 14046
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81316
NOVAMOXIN 250MG CAPSULE Discontinued 2020-01-24 2020-01-24 104289
NOVAMOXIN 25MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81393
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-10-25 2019-10-26 97251
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63955
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63959
NOVASEN 650MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63964
NOVO-PROFEN 400MG TABLET Discontinued 2018-10-19 2018-10-19 64920
NOVO-PROFEN 200MG TABLET Discontinued 2019-04-11 2019-04-11 81310
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.5G 4G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210194
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.375G 3G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210191
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64589
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64592
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64615
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64623
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64626